Insider Transactions in Q4 2025 at Iovance Biotherapeutics, Inc. (IOVA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2025
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,426
-0.94%
|
$8,852
$2.14 P/Share
|
|
Dec 02
2025
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,417
+2.17%
|
-
|
|
Dec 02
2025
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,786
-1.66%
|
$3,572
$2.14 P/Share
|
|
Dec 02
2025
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,516
+3.17%
|
-
|
|
Dec 02
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,984
-1.75%
|
$3,968
$2.14 P/Share
|
|
Dec 02
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,906
+3.32%
|
-
|
|
Dec 01
2025
|
Raj K. Puri Chief Regulatory Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,467
-1.13%
|
$4,934
$2.23 P/Share
|
|
Dec 01
2025
|
Raj K. Puri Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,469
+2.44%
|
-
|
|
Dec 01
2025
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
17,701
-3.72%
|
$35,402
$2.23 P/Share
|
|
Dec 01
2025
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
41,669
+8.05%
|
-
|
|
Dec 01
2025
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,464
-4.12%
|
$8,928
$2.23 P/Share
|
|
Dec 01
2025
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,789
+7.49%
|
-
|
|
Dec 01
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,464
-3.91%
|
$8,928
$2.23 P/Share
|
|
Dec 01
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,789
+7.15%
|
-
|